Tetrahydroisoquinoline alkaloids are a class of structurally complex natural products and a huge number of its natural product widely exist in nature which, from the discovery has been more than a century, it compounds with high anti-tumor activity, antibacterial and other physical activity, but also because of its special structure, with low oncentration of biological activity, but these alkaloids are not sold in the market mainly due to a less natural extraction, chemical synthesis method and multi-step, low yield. Therefore, we constructed a combination of tetrahydroisoquinoline alkaloids and the pyrazino [2,1-b] quinazoline-3,6-diones structure of the new compounds, which have the quinazolinone compounds which is the drug synthesis and drug activity on the bond, is also a kind of unique and widely used drug structure, and causes a lot of scientists and drug research interest and discussion, as we develop the motivation.

The tetrahydroisoquinoline alkaloids have been studied thoroughly about their biological and chemical significance over the past 30 years. These natural products show great biological activity, especially ET-743 and saframycin A, makes them promising therapeutics, while their structural complexity and particularity provide challenging synthetic targets. These alkaloids or derivatives show interesting biological activity, but the most important drawback as potential market therapeutics is the minute amount of them available from nature, and the synthetic methods published are inconvenient, difficult, and hard to handle. Herein is described our researches about the tetrahydroisoquinoline alkaloids. Chapter 1 describes relevant background related to the biological significance of these alkaloids, and the currently synthetic studies toward these natural products. Chapter 2 describes our design and synthesis of the analogues based on the anticancer mechanism of the tetrahydroisoquinoline alkaloids, and the biological activities of these analogues. Chapter 3 describes a rapid synthetic route for the common structure of the bis-tetrahydroisoquinoline alkaloids via a controlled mono-Pictet-Spengler cyclization.

Cette thèse est fondée sur le développement de nouvelles méthodes de criblage et d’analyse appliquées aux extraits naturels. Le premier axe de ce travail a consisté à isoler une molécule très minoritaire dans un mélange réactionnel de synthèse biomimétique en utilisant entre autre la chromatographie de partage centrifuge (CPC) en mode pH-zone refining. Nous avons pu isoler la nitrarine avec un rendement de 0,04% en permettant de valider le mécanisme proposé pour sa synthèse biomimétique.Le deuxième axe de ce projet est consacré à l’identification par fractionnement bioguidé, dans les graines de Mucuna pruriens (une plante de la pharmacopée traditionnelle indienne), des molécules responsables de la synergie thérapeutique antiparkinsonienne mise en évidence dans la littérature par des essais in vivo et cliniques. L’extrait hydro-alcoolique de graines de Mucuna pruriens a été fractionné par chromatographie sur colonne de gel de silice, puis les fractions obtenues ont été évaluée in vitro sur plusieurs cibles biologiques : enzymes de dégradation de la dopamine (MAO, COMT), et une enzyme de sa synthèse endogène (DDC). Nous avons développé une méthodes de détection d’une activité d’inhibition de ces enzymes par spectrométrie de masse. À partir des fractions identifiées comme étant actives, nous avons isolé et identifié une vingtaine de molécules, parmi lesquelles une dizaine sont nouvellement décrites. Il a été nécessaire de synthétiser certaines d'entre elles en raison de la quantité nécessaire aux essais biologiques. Certaines de ces molécules ont montré une activité inhibitrice intéressante sur la COMT / This thesis is based on the development of new methods of screening and analysis applied to natural extracts.The first axis of this work consisted in isolating a minoritary molecule in a reaction mixture of a biomimetic synthesis using different techniques including centrifugal partition chromatography (CPC) in pH-zone refining mode. We were able to isolate the nitrarine with a yield of 0.04%, thus allowing to validate the proposed mechanism of its biomimetic synthesis.The second axis of this project is dedicated to the identification in the seeds of Mucuna pruriens (a plant of Indian traditional pharmacopoeia), by bioguided fractionation, the molecules responsible for the antiparkinsonian synergy demonstrated by in vivo studies and clinical trials. For this purpose, the hydroalcoholic extract of M. pruriens seeds was fractionated by chromatography on a silica gel column and the obtained fractions were evaluated in vitro on various biological targets: the dopamine-degrading enzymes (MAO, COMT) and an enzyme implicated in its endogenous synthesis (DDC). Moreover, we have developed a method to detect by mass spectrometry fractions or compounds having an inhibitory activity on these enzymes. From fractions identified as active, we isolated and identified about twenty molecules, from which a dozen are newly described. On the other hand, it was necessary to synthetize some of them due to the amount required by bioassays. Some of these molecules have shown an interesting inhibitory activity against the COMT enzyme